Loading clinical trials...
Loading clinical trials...
Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care: A Multi-Center Prospective Registry and Retrospective Data Collection Study
Conditions
Interventions
Vivigen Cellular Bone Matrix
Locations
4
United States
OrlandoHealth
Orlando, Florida, United States
RWJBarnabas Health
Jersey City, New Jersey, United States
Duke University Medical Center
Durham, North Carolina, United States
Sentara Hospitals
Norfolk, Virginia, United States
Start Date
June 1, 2021
Primary Completion Date
July 31, 2026
Completion Date
July 31, 2026
Last Updated
April 2, 2025
NCT05699174
NCT06560255
NCT06812481
NCT05701254
NCT05960591
NCT03903510
Lead Sponsor
LifeNet Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions